INR 876.0
(0.34%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 736.2 Million | 692.6 Million | -178.48 Million | 355.95 Million | 410.73 Million | 996.51 Million |
Net Income | 327.4 Million | 402.4 Million | 125.87 Million | -12.24 Million | 322.67 Million | 538.32 Million |
Depreciation & Amortization | 366.9 Million | 220.4 Million | 221.18 Million | 221.42 Million | 222.15 Million | 207.99 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 13.3 Million | - | - | - | - | - |
Change in working capital | -2.3 Million | 185.4 Million | -413.3 Million | 231.32 Million | -168.28 Million | 485.47 Million |
Other non-cash items | 823.2 Million | -115.6 Million | -112.23 Million | -84.54 Million | 34.19 Million | -235.27 Million |
Investing Cash Flow | -711.1 Million | -717.8 Million | -61.27 Million | -17.22 Million | -122.97 Million | -998.7 Million |
Investments in PPE | -1.58 Billion | -415.3 Million | -59.2 Million | -46.61 Million | -130.93 Million | -141.33 Million |
Acquisitions | - | 313 Thousand | 1.04 Million | 813 Thousand | 384 Thousand | 114 Thousand |
Investment purchases | -1.19 Billion | -1.03 Billion | -17.07 Million | -742 Thousand | -1.14 Million | -902.23 Million |
Sales/Maturities of investments | 2.14 Billion | 706 Million | -1.04 Million | -71 Thousand | 762 Thousand | 902.12 Million |
Other Investing Activities | -73.4 Million | 25.08 Million | 15 Million | 29.38 Million | 7.96 Million | -857.37 Million |
Financing Cash Flow | -7 Million | -3.8 Million | -79.49 Million | -78.33 Million | -211.24 Million | -200.57 Million |
Debt repayment | -7 Million | -3.75 Million | -3.49 Million | -2.33 Million | -1.28 Million | -1.92 Million |
Dividends payments | - | - | -76 Million | -76 Million | -91.62 Million | -98.85 Million |
Common Stock Repurchased | - | - | - | - | -112.71 Million | -99.85 Million |
Common Stock Issuance | - | - | - | - | 1.28 Million | -1.92 Million |
Other Financing Activities | -200 Thousand | -25 Thousand | -3.49 Million | -2.33 Million | -6.9 Million | 1.97 Million |
Accounts receivables | -161.4 Million | -15 Million | -62.3 Million | 50.24 Million | 9.33 Million | 1.95 Million |
Accounts payables | 71.1 Million | 93.69 Million | -402 Thousand | -27.58 Million | 25.74 Million | -19.72 Million |
Inventory | 45.1 Million | -155.6 Million | -12.89 Million | 6.92 Million | 7.18 Million | 1.8 Million |
Other working capital | 42.9 Million | 262.3 Million | -337.7 Million | 201.73 Million | -210.55 Million | 501.43 Million |
Cash at beginning of period | 51.36 Million | 35.3 Million | 354.5 Million | 94.1 Million | 17.58 Million | 221.6 Million |
Cash at end of period | 504.8 Million | 6.3 Million | 35.25 Million | 354.5 Million | 94.1 Million | 18.83 Million |
Capital Expenditure | -1.58 Billion | -415.3 Million | -59.2 Million | -46.61 Million | -130.93 Million | -141.33 Million |
Effect of forex changes on cash | - | - | 54 Thousand | 1000.00 | - | - |
Net cash flow / Change in cash | 453.43 Million | -29 Million | -319.25 Million | 260.39 Million | 76.52 Million | -202.76 Million |
Free Cash Flow | -850.7 Million | 277.3 Million | -237.68 Million | 309.34 Million | 279.79 Million | 855.18 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 181.9 Million | 327.4 Million | 122.5 Million | 60.3 Million | 94.2 Million | 50.4 Million |
Depreciation & Amortization | - | 366.9 Million | - | 9 Million | 8 Million | 6.9 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 13.3 Million | - | - | - | - |
Change in working capital | - | -2.3 Million | - | - | - | - |
Other non-cash items | -181.9 Million | 823.2 Million | -122.5 Million | -60.3 Million | -94.2 Million | -50.4 Million |
Investing Cash Flow | - | -711.1 Million | - | - | - | - |
Investments in PPE | - | -1.58 Billion | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -1.19 Billion | - | - | - | - |
Sales/Maturities of investments | - | 2.14 Billion | - | - | - | - |
Other Investing Activities | - | -73.4 Million | - | - | - | - |
Financing Cash Flow | - | -7 Million | - | - | - | - |
Debt repayment | - | -7 Million | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -200 Thousand | - | - | - | - |
Accounts receivables | - | -161.4 Million | - | - | - | - |
Accounts payables | - | 71.1 Million | - | - | - | - |
Inventory | - | 45.1 Million | - | - | - | - |
Other working capital | - | 42.9 Million | - | - | - | - |
Cash at beginning of period | - | 51.36 Million | - | 281.7 Million | 265.7 Million | 51.36 Million |
Cash at end of period | - | 504.8 Million | - | 299.7 Million | 281.7 Million | 65.16 Million |
Capital Expenditure | - | -1.58 Billion | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 453.43 Million | - | 18 Million | 16 Million | 13.8 Million |
Free Cash Flow | - | -850.7 Million | - | 18 Million | 16 Million | 13.8 Million |
UNH
002162
CNH
ULTP
GULFNAV
AARTIPHARM